DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

BIBLIOGRAPHY
Abe T, Kakyo M, Tokui T, et al. Identification of a novel gene
family encoding human liver-specific organic anion transporter
LST-1. J Biol Chem, 1999, 274:17159–17163.
Abramson J, Smirnova I, Kasho V, et al. Structure and
mechanism of the lactose permease of Escherichia coli.
Science, 2003, 301:610–615.
Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular,
and pharmacological aspects of the multidrug transporter.
Annu Rev Pharmacol Toxicol, 1998, 39:361–398.
Aoki M, Terada T, Kajiwara M, et al. Kidney-specific expression
of human organic cation transporter 2 (OCT2/SLC22A2) is
regulated by DNA methylation. Am J Physiol, 2008, 295:
F165–F170.
Begley DJ, Brightman MW. Structural and functional aspects of
the blood–brain barrier. Prog Drug Res, 2003, 61:39–78.
Belinsky MG, Guo P, Lee K, et al. Multidrug resistance protein
4 protects bone marrow, thymus, spleen, and intestine from
nucleotide analogue-induced damage. Cancer Res, 2007,
67:262-268.
Bobulescu A, Di Sole F, Moe OW. Na + /H + exchangers:
physiology and link to hypertension and organ ischemia. Mol
Cell Biol Physiol Solute Transport, 2005, 14:485–494.
Borst P, Elferink RO. Mammalian ABC transporters in health
and disease. Annu Rev Biochem, 2002, 71:537–592.
Breedveld P, Pluim D, Cipriani G, et al. The effect of BCRP1
(ABCG2) on the in vivo pharmacokinetics and brain
penetration of imatinib mesylate (Gleevec): implications for
the use of breast cancer resistance protein and P-glycoprotein
inhibitors to enable the brain penetration of imatinib in
patients. Cancer Res, 2005, 65:2577–2582.
Büchler M, König J, Brom M, et al. cDNA cloning of the
hepatocyte canalicular isoform of the multidrug resistance
protein, cMRP, reveals a novel conjugate export pump
deficient in hyperbilirubinemic mutant rats. J Biol Chem,
1996, 271:15091–15098.
Burckhardt BC, Burckhardt G. Transport of organic anions
across the basolateral membrane of proximal tubule cells. Rev
Physiol Biochem Pharmacol, 2003, 146:95–158.
Burman J, Tran CH, Glatt C, et al. The effect of rare human
sequence variants on the function of vesicular monoamine
transporter 2. Pharmacogenetics, 2004, 14:587–594.
Cha SH, Sekine T, Kusuhara H, et al. Molecular cloning and
characterization of multispecific organic anion transporter 4
expressed in the placenta. J Biol Chem, 2000, 275:4507–4512.
Chang C, Swaan PW, Ngo LY, et al. Molecular requirements of
the human nucleoside transporters hCNT1, hCNT2, and
hENT1. Mol Pharmacol, 2004, 65:558–570.
Chen NH, Reith ME, Quick MW. Synaptic uptake and beyond:
the sodium- and chloride-dependent neurotransmitter
transporter family SLC6. Pflugers Arch, 2004, 447:519–531.
Chen Y, Zhang S, Sorani M, Giacomini KM. Transport of
paraquat by human organic cation transporters and multidrug
and toxic compound extrusion family. J Pharmacol Exp Ther,
2007, 322:695–700.
Ciarimboli G. Organic cation transporters. Xenbiotica, 2008,
38:936–971.
Clarke ML, Mackey JR, Baldwin SA, et al. The role of
membrane transporters in cellular resistance to anticancer
nucleoside drugs. Cancer Treat Res, 2002, 112:27–47.
Cropp CD, Komori T, Shima JE, et al. Organic anion transporter
2 (SLC22A7) is a facilitative transporter of cGMP. Mol
Pharmacol, 2008, 73:1151–1158.
Cui Y, Konig J, Keppler D. Vectorial transport by doubletransfected
cells expressing the human uptake transporter
SLC21A8 and the apical export pump ABCC2. Mol
Pharmacol, 2001, 60:934–943.
Dawson RJ, Locher KP. Structure of a bacterial multidrug ABC
transporter. Nature, 2006, 443:180–185.
Dawson RJ, Locher KP. Structure of the multidrug ABC
transporter Sav1866 from Staphylococcus aureus in complex
AMP-PNP. FEBS Lett, 2007, 581:935–938.
Dobson PD, Kell DB. Carrier-mediated cellular uptake of
pharmaceutical drugs: An exception or the rule? Nature Rev,
2008, 7:205–220.
Ekaratanawong S, Anzai N, Jutabha P, et al. Human organic anion
transporter 4 is a renal apical organic anion/dicarboxylate
exchanger in the proximal tubules. J Pharmacol Sci, 2004,
94:297–304.
Elliott J, Beveridge T. Psychostimulants and monoamine transporters:
Upsetting the balance. Curr Opin Pharmacol, 2005, 5:94–100.
Enomoto A, Kimura H, Chairoungdua A, et al. Molecular
identification of a renal urate anion exchanger that regulates
blood urate levels. Nature, 2002, 417:447–452.
El-Sheikh AK, Masereeuw R, Russel F. Mechanisms of
renal anionic drug transport. Eur J Pharmacol, 2008, 585:
245–255.
Enokizono J, Kusuhara H, Ose A, et al., Quantitative investigation
of the role of breast cancer resistance protein (Bcrp/Abcg2) in
limiting brain and testis penetration of xenobiotic compounds.
Drug Metab Dispos, 2008, 36:995–1002.
Enokizono J, Kusuhara H, Sugiyama Y. Effect of breast cancer
resistance protein (Bcrp/Abcg2) on the disposition of
phytoestrogens. Mol Pharmacol, 2007, 72:967–975.
Faham S, Watanabe A, Besserer GM, et al. The crystal structure
of a sodium galactose transporter reveals mechanistic insights
into Na + /sugar symport. Science, 2008, 321:810–814.
Gether U, Anderson PH, Larsson OM, Schousboe A.
Neurotransmitter transporters: molecular function of important
drug targets. Trends Pharmacol Sci, 2006, 27:375–383.
Gerloff T, Stieger B, Hagenbuch B, et al. The sister of
P-glycoprotein represents the canalicular bile salt export pump
of mammalian liver. J Biol Chem, 1998, 273:10046–10050.
Gray JH, Mangravite LM, Owen RP. Functional and genetic
diversity in the concentrative nucleoside transporter, CNT1, in
human populations. Mol Pharmacol, 2004, 65:512–519.
Hagenbuch B, Scharschmidt BF, Meier PJ. Effect of antisense
oligonucleotides on the expression of hepatocellular bile acid
and organic anion uptake systems in Xenopus laevis oocytes.
Biochem J, 1996, 316:901–904.
Hagenbuch B, Stieger B, Foguet M, et al. Functional expression
cloning and characterization of the hepatocyte Na + /bile acid
cotransport system. Proc Natl Acad Sci USA, 1991, 88:10629–
10633.
Hahn MK, Blakely RD. The functional impact of SLC6
transporter genetic variation. Annu Rev Pharmacol Toxicol,
2007, 47:401–441.
Han JY, Lim HS, Yoo YK, et al. Associations of ABCB1, ABCC2,
and ABCG2 polymorphisms with irinotecan—pharmacokinetics
and clinical outcome in patients with advanced non-small cell
lung cancer. Cancer, 2007, 110:138–147.
117
CHAPTER 5
MEMBRANE TRANSPORTERS AND DRUG RESPONSE